Background: Previous studies have shown that sexually transmitted infections (STI) and human immunodeficiency virus (HIV) testing has varied, but STI prevalence was not estimated among patients during their health care visits in which a high-risk sexual partnership was documented. This study estimated gonorrhea, chlamydia, syphilis, and HIV testing rates and chlamydia and gonorrhea prevalence.
Methods: From the de-identified commercial claims data of OptumLabs Data Warehouse, we identified men and women aged 15-60 years classified as having high-risk sexual relationships as diagnosis codes: Z72.51 for opposite-sex, Z72.52 for same-sex, and Z72.53 for same-and-opposite-sex relationships, stratified by gender, age group, region, type of health plan, and HIV status. We estimated STI testing rate and prevalence for chlamydia and gonorrhea among patients with high-risk sexual relationships. HIV testing was assessed only in high-risk sexual relationship patients without HIV.
Results: Among 8.2 million females and 7.3 million males aged 15-60 years in the database from 2016 to 2019, 115,884 patients (0.7% of female, 0.8% of male) including 3,535 patients with HIV were diagnosed with high-risk sexual relationships. The testing rates for gonorrhea, chlamydia, syphilis, and HIV were 69.4% (confidence interval [CI]: 69.1-69.7), 68.9% (CI: 68.6-69.2), 43.4% (CI: 43.1-43.7), and 41.7% (CI: 41.4-42.0), respectively. Among patients with valid chlamydia and gonorrhea tests, 7.2% (CI: 7.0-7.5) and 2.6% (CI: 2.4-2.8) had positive chlamydia and gonorrhea test results, respectively, and varied by type of high-risk sexual relationship.
Conclusions: Our study findings of suboptimal STI screening among patient in high-risk sexual relationships are consistent with previous studies. Administrative records confirmed by lab results indicate a need for STI counseling, testing, and treatment among patients who are diagnosed with high-risk sexual relationships with same-sex, opposite-sex, or same-and-opposite sex partners.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186198 | PMC |
| http://dx.doi.org/10.1016/j.amjmed.2021.09.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence and associated factors of recent HIV-1 infection among newly identified HIV-positive individuals tested with the Asante Rapid Recency assay in Harari region, Eastern Ethiopia.
Front Epidemiol
February 2025
School of Public, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Background: Human immunodeficiency virus (HIV) is a virus that attacks the immune system. Globally, more than 79.3 million people have been infected with it, and about 36.
View Article and Find Full Text PDFMental Health Challenges in Cancer Survivors From Diverse Backgrounds During COVID-19 Pandemic: Insights From the All of Us Research Program.
Psychooncology
March 2025
Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Background: The COVID-19 pandemic exacerbated mental health challenges. This study aimed to investigate the mental health impact of the pandemic on cancer survivors from diverse backgrounds using the All of Us Research Program's COVID-19 Participant Experience (COPE) survey.
Methods: This analysis included respondents of the COPE survey with average depression, anxiety, and self-harm metrics computed for individuals completing multiple survey iterations.
An Integrated Intervention to Reduce HIV Risk Behaviors Among Heterosexual HIV-Negative, African American Couples: Pilot Feasibility, Acceptability, and Usefulness Study.
AIDS Behav
March 2025
Department of Family Science, School of Public Health, University of Maryland, College Park, Maryland, USA.
Synergistic interactions between substance use and violence (SAVA syndemic) are strongly associated with heightened risk for HIV acquisition in the African American population. While couple-based interventions have shown efficacy among at-risk and HIV-positive serodiscordant couples, no interventions have specifically targeted SAVA syndemic risk reduction for HIV-negative, high-risk, heterosexual African American couples in the United States. This pilot study tested the feasibility, safety, and preliminary effects of an integrated sexual risk reduction intervention for African American couples.
View Article and Find Full Text PDFHuman Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence.
J Pharm Bioallied Sci
December 2024
Division of Dental Public Health, General Dentistry Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Human papillomavirus (HPV) represents the most common sexually transmitted infection globally, exerting a substantial impact on sexual and reproductive health, with a high oncogenic potential leading to various malignancies. The prevalence of HPV in Saudi Arabia ranges from 9% to 43%, with types 16, 18, and 45 being the most common high-risk strains. Despite the availability of effective vaccines such as Gardasil 9, Gardasil, and Cervarix, proper awareness and vaccination rates remain low in Saudi Arabia.
View Article and Find Full Text PDFThe increasing use of antiviral drugs, combined with an aging population, has resulted in a growing number of older adults living with HIV. Unfortunately, high-risk sexual behavior among older individuals with HIV has led to HIV retransmission. Our study aimed to analyze the sexual behavior of elderly men with HIV in Chongqing and evaluate the factors influencing high-risk sexual behavior using a logistic regression model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!